Procter & Gamble Health Q2 Results FY27: Revenue Up 17.72% YoY to Rs 382.49 Cr, PAT Rs 111.51 Cr
- November 2, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Procter & Gamble Health Q2 Results FY27 were declared on 2 November 2026 on a Standalone basis. The quarterly results show revenue of Rs 382.49 Cr, up 17.72% YoY from Rs 324.92 Cr. Net profit was Rs 111.51 Cr against Rs 88.54 Cr a year earlier, a YoY growth of 25.94%.
Procter & Gamble Health Ltd (PGHL) Q2 Results FY27 announced on 2 November 2026, covering the company’s financial performance for the July to September quarter. The company reported revenue of Rs 382.49 Cr and PAT of Rs 111.51 Cr. These figures were declared on the Standalone basis, and the results date of 2 November 2026 anchors every comparison below. The article reads Procter & Gamble Health Q2 Results FY27 as filed.
This Procter & Gamble Health Q2 Results results analysis covers the financial highlights, the business drivers disclosed in the data, the outlook framework and the risks worth tracking. It also sets out how standalone results for the quarter compare with the prior year, starting with the Financial Highlights table that follows.
Click Here – Get Free Investment Predictions
Procter & Gamble Health Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 382.49 Cr | Rs 324.92 Cr | +17.72% YoY |
| Operating Profit | Rs 152.37 Cr | Rs 120.27 Cr | +26.69% YoY |
| Net Profit (PAT) | Rs 111.51 Cr | Rs 88.54 Cr | +25.94% YoY |
Source: company filing for Procter & Gamble Health Q2 Results FY27, 2 November 2026. Figures in Rs Crore, Standalone basis.
Key Takeaways from Procter & Gamble Health Q2 Results: What Stands Out
- Revenue Rs 382.49 Cr: sales grew 17.72% from Rs 324.92 Cr in the same quarter last year, a solid rise on a standalone basis.
- Net profit Rs 111.51 Cr: PAT rose 25.94% YoY from Rs 88.54 Cr, so the YoY growth in net profit is positive in Procter & Gamble Health Q2 Results FY27.
- Operating Profit Rs 152.37 Cr: this line grew 26.69% from Rs 120.27 Cr in the comparison quarter, a little faster than net profit.
- Net profit margin 29.2%: the margin improved from 27.2% in the comparison quarter, which is the clearest single marker of the quarter.
- Annual backdrop: return on equity was 62.18% in FY26, and the performance analysis below sets the quarter against it.
Procter & Gamble Health Q2 Results FY27: Performance Analysis
The numbers show growth across every reported line. Revenue came in at Rs 382.49 Cr against Rs 324.92 Cr, Operating Profit at Rs 152.37 Cr against Rs 120.27 Cr, and net profit at Rs 111.51 Cr against Rs 88.54 Cr in the same quarter last year. Revenue added Rs 57.57 Cr and net profit added Rs 22.97 Cr.
Within Procter & Gamble Health Q2 Results FY27, net profit grew faster than revenue. Revenue was up 17.72%, Operating Profit was up 26.69% and net profit was up 25.94%. The supplied data confirms these movements but does not establish the specific cause behind them. This Procter & Gamble Health Q2 Results keeps the focus on verified figures and on arithmetic comparisons between the lines.
Net profit of Rs 111.51 Cr on revenue of Rs 382.49 Cr works out to a margin of 29.2%, compared with 27.2% a year earlier. For this results analysis, the YoY growth readings and the quarterly results trend are the key markers, and the disclosed drivers appear in the business factors that follow.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue and Net Profit Growth – The results analysis points first to the top line and the profit line. Revenue grew 17.7% year on year to Rs 382.49 Cr, and net profit rose 25.9% year on year to Rs 111.51 Cr, which together define the quarterly results.
Margin Improvement – Net profit margin improved to 29.2% from 27.2% in the comparison quarter. Read alongside Procter & Gamble Health Q2 Results FY27, this shows that profit grew faster than sales, and it supports the 25.94% YoY growth figure.
Return on Equity – Return on equity was 62.18% in FY26. This is a disclosed annual measure rather than a quarterly one, and it frames the Q2 numbers against a high annual return profile.
FY27 Outlook After Procter & Gamble Health Q2 Results
FY27 full-year results will depend on subsequent quarters and on conditions the company discloses later, and the Univest Screener tracks each new filing. The FY27 view therefore rests on what the Q2 numbers show: standalone revenue of Rs 382.49 Cr and net profit of Rs 111.51 Cr.
In Procter & Gamble Health Q2 Results FY27, the results analysis shows that later disclosures will test whether the margin of 29.2% repeats, because the comparison quarter margin was 27.2%. Net profit comparisons depend on how the quarterly pattern settles, and the points to watch lead directly into the risks.
Key Risks to Watch After Procter & Gamble Health Q2 Results FY27
Pace of Revenue Growth
Revenue grew 17.72% YoY to Rs 382.49 Cr, slower than the 25.94% growth in net profit. Following Procter & Gamble Health Q2 Results FY27, a gap of this kind means profit growth rests on margin, so next quarter’s revenue is a key figure.
Dependence on Margin
Net profit margin of 29.2% against 27.2% a year ago carries the profit growth of 25.94%. Later disclosures will show whether that margin level is repeated, so investors will track it alongside YoY growth.
Annual Return Level
Return on equity was 62.18% in FY26. This annual measure sits behind the quarterly numbers and affects how the latest quarter is read against the year, so it stays on the watch list for later quarters.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Procter & Gamble Health Q2 Results FY27 show standalone revenue of Rs 382.49 Cr and net profit of Rs 111.51 Cr, both higher year on year. The Procter & Gamble Health Q2 Results picture is one of steady growth with profit rising faster than sales, and the quarterly results are best read with the next standalone results disclosure. Investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Procter & Gamble Health Q2 Results FY27
What are Procter & Gamble Health Q2 Results FY27?
Ans. Procter & Gamble Health Q2 Results FY27 are the quarterly results of Procter & Gamble Health for July to September 2026, covering revenue and net profit, while the Financial Highlights section sets out each figure against the prior year.
What is the results date for Procter & Gamble Health Q2 Results FY27?
Ans. Procter & Gamble Health declared its standalone results on 2 November 2026, which is the results date, so every figure in the Performance Analysis section reflects that filing.
What revenue was reported in Procter & Gamble Health Q2 Results FY27?
Ans. Procter & Gamble Health reported revenue of Rs 382.49 Cr, compared with Rs 324.92 Cr a year earlier, which means sales were higher by 17.72% YoY, as the Key Takeaways section shows.
What net profit was reported in Procter & Gamble Health Q2 Results FY27?
Ans. Procter & Gamble Health reported net profit of Rs 111.51 Cr for Q2 FY27, compared with Rs 88.54 Cr a year earlier, which is a rise of 25.94% as the Financial Highlights table shows.
How much YoY growth did revenue show in Procter & Gamble Health Q2 Results FY27?
Ans. Revenue showed YoY growth of 17.72% in Q2 FY27, moving from Rs 324.92 Cr to Rs 382.49 Cr, which is why the Performance Analysis places revenue growth behind the profit growth rate.
Did net profit rise or fall in Procter & Gamble Health Q2 Results?
Ans. Procter & Gamble Health Q2 Results show that net profit rose to Rs 111.51 Cr from Rs 88.54 Cr, so the YoY change is up 25.94%, a move discussed in the Performance Analysis section.
What was the Operating Profit in Procter & Gamble Health Q2 Results FY27?
Ans. Procter & Gamble Health posted Operating Profit of Rs 152.37 Cr, compared with Rs 120.27 Cr last year, so it rose 26.69% YoY, as the Key Takeaways section sets out.
Are Procter & Gamble Health Q2 Results consolidated results or standalone results?
Ans. Procter & Gamble Health Q2 Results are standalone results, meaning the figures cover the company on its own basis, so the Financial Highlights table should be read as a standalone comparison with the prior year.
What business factors shaped Procter & Gamble Health Q2 Results FY27?
Ans. The disclosed factors are revenue and net profit growth, a margin of 29.2% against 27.2% and return on equity of 62.18% in FY26, so the Key Business Factors section explains each of them.
What are the key risks after Procter & Gamble Health Q2 Results FY27?
Ans. The points to watch are revenue growth of 17.72% against net profit growth of 25.94%, the margin of 29.2% and the 62.18% annual return on equity, so the Key Risks section lists each figure.
What is the outlook after Procter & Gamble Health Q2 Results?
Ans. The FY27 outlook rests on later quarters, while the margin of 29.2% against 27.2% a year ago shows the level that later disclosures will be compared with, as the Outlook section notes.
Where can I find the complete Procter & Gamble Health Q2 Results FY27 data?
Ans. The complete Procter & Gamble Health Q2 Results FY27 data is in the Financial Highlights table on this page, which compares revenue, Operating Profit and net profit with the prior year, and the Univest Screener lists related companies.
